[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Hill et al., 1988 - Google Patents

Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak

Hill et al., 1988

Document ID
947603029467372937
Author
Hill R
Duckworth G
Casewell M
Publication year
Publication venue
Journal of Antimicrobial Chemotherapy

External Links

Snippet

During a hospital outbreak of methicillin-resistant Staphylococcus aureus (MRSA), involving more than 200 patients, 40 patients and 32 hospital staff who were stable nasal carriers of MRSA received topical application of 2% mupirocin. formulated in a white soft paraffin and …
Continue reading at academic.oup.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Hill et al. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak
Duckworth et al. Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital
Levin et al. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine
Stamm et al. Wound infections due to group A streptococcus traced to a vaginal carrier
Archer et al. Antibiotic-resistant Staphylococcus epidermidis in patients undergoing cardiac surgery
Smith et al. Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations
Parras et al. Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus
Fulton et al. Gram-negative folliculitis in acne vulgaris
Saroglou et al. Methicillin-resistant Staphylococcus aureus: interstate spread of nosocomial infections with emergence of gentamicin-methicillin resistant strains
Scopp et al. Gingival degerming by povidone-iodine irrigation: bacteremia reduction in extraction procedures
Talan et al. Staphylococcus intermedius: clinical presentation of a new human dog bite pathogen
Fahmy et al. BACTERIAL FLORA IN RELATION TO CATARACT EXTRACTION: III. Postoperative Flora
Aeilts et al. Methicillin-resistant-Staphylococcus aureus colonization and infection in a rehabilitation facility
Haughey et al. Use of antibiotics in the initial management of soft tissue hand wounds
Vandenbroucke-Grauls et al. Control of epidemic methicillin-resistant Staphylococcus aureus in a Dutch university hospital
Shanson et al. Control of a hospital outbreak of methicillin-resistant Staphylococcus aureus infections: value of an isolation unit
Smith et al. Epidemiology of ciprofloxacin resistance among patients with methicillin-resistant Staphylococcus aureus
Henderson et al. Nasal disinfection in prevention of post-operative staphylococcal infection of wounds
Kominos et al. Mode of transmission of Pseudomonas aeruginosa in a burn unit and an intensive care unit in a general hospital
Ellison III et al. Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections
Steele Recurrent staphylococcal infection in families
Witte et al. Analysis of nosocomial outbreaks with multiply and methicillin-resistant Staphylococcus aureus (MRSA) in Germany: implications for hospital hygiene
Singh et al. Bacteriology of psoriatic plaques
Ransjo et al. Methicillin-resistant Staphylococcus aureus in two burn units: clinical significance and epidemiological control
Karyoute Burn wound infection in 100 patients treated in the burn unit at Jordan University Hospital